ARC and Roche collaborate to enhance NSCLC diagnostics using AI
Sheba Medical Center's innovation arm, Accelerate, Redesign, and Collaborate (ARC), has partnered with Roche to advance the diagnosis and treatment…
Oncology
-
-
Roche secures CE mark for ovarian cancer detection test
Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, for the…
-
Mursla Bio’s EvoLiver blood test shows promise in HCC surveillance
Mursla Bio has revealed outcomes from the MEV01 clinical study of its ‘EvoLiver’ blood test for the surveillance of hepatocellular…
-
Densitas launches intelliRisk platform for breast cancer management
Densitas has launched the intelliRisk platform, its latest solution for high-risk breast cancer patient management. This new platform joins the…
-
GE HealthCare eyes AI breast cancer detection with DeepHealth partnership
GE HealthCare is reinforcing its application of artificial intelligence (AI) in imaging workflows with yet another partnership, this time with…
-
IceCure’s cryoablation system for breast cancer treatment gains FDA panel support
IceCure Medical has received a favourable recommendation for its ‘ProSense’ Cryoablation System from the Medical Device Advisory Committee Panel of the…
-
Castle boasts melanoma test’s capacity to reduce unnecessary testing
Castle Biosciences has released data from a multicenter DECIDE study showing the impact of integrating its DecisionDx-Melanoma test results into…
-
Mayo Clinic develops mesothelioma detection method
Researchers at the Mayo Clinic in the US have developed a new testing strategy aimed at improving mesothelioma cancer deoxyribonucleic…
-
PrognomiQ secures funding to advance lung cancer detection test
PrognomiQ has closed its Series D financing round, securing $34m, for advancing the development of an early lung cancer detection…
-
Biofrontera stock climbs as drug-device succeeds in Phase III skin cancer trial
Biofrontera has announced topline results from a Phase III trial evaluating its drug-device therapy, Ameluz gel and photodynamic therapy (PDT)…
